BioCryst/$BCRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About BioCryst
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Ticker
$BCRX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
580
ISIN
US09058V1035
Website
BioCryst Metrics
BasicAdvanced
$2.3B
-
-$0.26
1.07
-
Price and volume
Market cap
$2.3B
Beta
1.07
52-week high
$11.31
52-week low
$5.92
Average daily volume
5.9M
Financial strength
Current ratio
2.931
Quick ratio
2.778
Long term debt to equity
-175.276
Total debt to equity
-183.501
Interest coverage (TTM)
0.35%
Management effectiveness
Return on assets (TTM)
4.54%
Return on equity (TTM)
11.52%
Valuation
Price to revenue (TTM)
4.548
Price to book
-5.11
Price to tangible book (TTM)
-5.11
Price to free cash flow (TTM)
-85.167
Growth
Revenue change (TTM)
41.67%
Earnings per share change (TTM)
-75.60%
3-year revenue growth (CAGR)
38.86%
3-year earnings per share growth (CAGR)
-37.67%
What the Analysts think about BioCryst
Analyst ratings (Buy, Hold, Sell) for BioCryst stock.
BioCryst Financial Performance
Revenues and expenses
BioCryst Earnings Performance
Company profitability
BioCryst News
AllArticlesVideos
BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
GlobeNewsWire·3 days ago
BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All Ages
GlobeNewsWire·6 days ago
BioCryst to Present at Upcoming Investor Conferences
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioCryst stock?
BioCryst (BCRX) has a market cap of $2.3B as of June 05, 2025.
What is the P/E ratio for BioCryst stock?
The price to earnings (P/E) ratio for BioCryst (BCRX) stock is 0 as of June 05, 2025.
Does BioCryst stock pay dividends?
No, BioCryst (BCRX) stock does not pay dividends to its shareholders as of June 05, 2025.
When is the next BioCryst dividend payment date?
BioCryst (BCRX) stock does not pay dividends to its shareholders.
What is the beta indicator for BioCryst?
BioCryst (BCRX) has a beta rating of 1.07. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.